Appraising the Evolving Landscape of Protease Inhibition in Osteoarthritis
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Latourte A, Jaulerry S, Combier A, Cherifi C, Jouan Y, Grange T
. SerpinA3N limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leucocyte elastase. Ann Rheum Dis. 2024; 83(12):1781-1790.
DOI: 10.1136/ard-2024-225645.
View
2.
Neuhold L, Killar L, Zhao W, Sung M, Warner L, Kulik J
. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest. 2001; 107(1):35-44.
PMC: 198546.
DOI: 10.1172/JCI10564.
View
3.
Little C, Barai A, Burkhardt D, Smith S, Fosang A, Werb Z
. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum. 2009; 60(12):3723-33.
PMC: 2832925.
DOI: 10.1002/art.25002.
View
4.
Vandenbroucke R, Libert C
. Is there new hope for therapeutic matrix metalloproteinase inhibition?. Nat Rev Drug Discov. 2014; 13(12):904-27.
DOI: 10.1038/nrd4390.
View
5.
Glasson S, Askew R, Sheppard B, Carito B, Blanchet T, Ma H
. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature. 2005; 434(7033):644-8.
DOI: 10.1038/nature03369.
View